BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a report published on Friday. The firm issued a sell rating on the medical technology company’s stock. BIOLASE Price Performance Shares of NASDAQ BIOL opened at $0.01 on Friday. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94. The […]
StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a report published on Friday. The firm issued a sell rating on the medical technology company’s stock. BIOLASE Price Performance Shares of NASDAQ BIOL opened at $0.01 on Friday. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94. The […]
